Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-16-017842
Filing Date
2016-11-14
Accepted
2016-11-14 06:04:13
Documents
8
Period of Report
2016-11-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp70217_6k.htm 6-K 13497
2 EXHIBIT 99.1 dp70217_ex9901.htm EX-99.1 245524
3 EXHIBIT 99.2 dp70217_ex9902.htm EX-99.2 116617
4 EXHIBIT 99.3 dp70217_ex9903.htm EX-99.3 29133
5 GRAPHIC header.gif GRAPHIC 1136
6 GRAPHIC image_008.jpg GRAPHIC 2044
7 GRAPHIC logo1.jpg GRAPHIC 3772
8 GRAPHIC logo2.jpg GRAPHIC 1080
  Complete submission text file 0000950103-16-017842.txt   417224
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 161989989
SIC: 2834 Pharmaceutical Preparations